resolvin-d5 and Pancreatic-Neoplasms

resolvin-d5 has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for resolvin-d5 and Pancreatic-Neoplasms

ArticleYear
Arachidonate 15-lipoxygenase-mediated production of Resolvin D5
    Frontiers in immunology, 2023, Volume: 14

    Activation of pancreatic stellate cells (PSCs) to cancer-associated fibroblasts (CAFs) is responsible for the extensive desmoplastic reaction observed in PDAC stroma: a key driver of pancreatic ductal adenocarcinoma (PDAC) chemoresistance leading to poor prognosis. Specialized pro-resolving mediators (SPMs) are prime modulators of inflammation and its resolution, traditionally thought to be produced by immune cells. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based lipid mediator profiling PSCs as well as primary human CAFs express enzymes and receptors to produce and respond to SPMs. Human PSC/CAF SPM secretion profile can be modulated by rendering these cells activated [transforming growth factor beta (TGF-β)] or quiescent [all-

    Topics: Arachidonate 15-Lipoxygenase; Carcinoma, Pancreatic Ductal; Chromatography, Liquid; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Pancreatic Stellate Cells; Tandem Mass Spectrometry; Tretinoin

2023